Enhanced Pathogen Identification Among Patients with Clinically Suspected Meningitis

Overview

Journal S Afr J Infect Dis

Date 2025 Jan 17

PMID 39822283

Authors

Malefu Moleleki

Pieter Nel

Siphiwe R Matukane

Stephanie Cloete

Zayaan Abrahams

Nicole Wolter

Andrew C Whitelaw

Affiliations

Soon will be listed here.

Abstract

Background: Delayed or incorrect treatment of meningitis may result in adverse patient outcomes. However, laboratory testing in resource-limited settings is often limited to conventional diagnostic methods. We explored the utility of syndromic molecular assays for diagnosis.

Objectives: We tested cerebrospinal fluid (CSF) specimens collected from patients with clinically suspected meningitis submitted to a tertiary hospital laboratory in January 2021 - May 2021. Primary microbiological analysis (culture, Gram stain and cytochemical analysis) was performed as part of routine testing.

Method: Residual CSF specimens were tested using a bacterial triplex real-time polymerase chain reaction (PCR) assay and a syndromic multi-pathogen real-time PCR assay for the detection of up to 18 bacterial and viral pathogens. Pathogen detection was compared between conventional and molecular assays.

Results: A potential pathogen was detected in 6% (12/188) and 47% (89/188) of specimens on the triplex and the multi-pathogen assay, respectively. Epstein-Barr virus (49/188; 26%), human herpes virus 7 (22/188; 12%), herpes simplex virus 1 (13/188; 7%) and (10/188; 5%) were the leading pathogens detected on the syndromic multi-pathogen PCR. Further, using the multi-pathogen PCR assay, a potential pathogen was detected in 44% (73/166) of the specimens which were negative following routine testing. Overall, combining routine testing and molecular platforms significantly improved pathogen detection ( < 0.001); a potential pathogen was identified in 51% (95/188) of the specimens tested, compared to 12% (22/188) using routine methods alone.

Conclusion: The use of molecular tests improved pathogen detection by 39% when paired with routine methods.

Contribution: Multi-pathogen molecular testing is useful for rapidly diagnosing meningitis cases.

References

Mwenda J, Soda E, Weldegebriel G, Katsande R, Biey J, Traore T . Pediatric Bacterial Meningitis Surveillance in the World Health Organization African Region Using the Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2011-2016. Clin Infect Dis. 2019; 69(Suppl 2):S49-S57. PMC: 6736400. DOI: 10.1093/cid/ciz472. View

. Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023; 22(8):685-711. PMC: 10356620. DOI: 10.1016/S1474-4422(23)00195-3. View

Kwambana-Adams B, Liu J, Okoi C, Mwenda J, Mohammed N, Tsolenyanu E . Etiology of Pediatric Meningitis in West Africa Using Molecular Methods in the Era of Conjugate Vaccines against Pneumococcus, Meningococcus, and Type b. Am J Trop Med Hyg. 2020; 103(2):696-703. PMC: 7410464. DOI: 10.4269/ajtmh.19-0566. View

Tchatchouang C, Fri J, De Santi M, Brandi G, Schiavano G, Amagliani G . Listeriosis Outbreak in South Africa: A Comparative Analysis with Previously Reported Cases Worldwide. Microorganisms. 2020; 8(1). PMC: 7023107. DOI: 10.3390/microorganisms8010135. View

Weinberg G, Schnabel K, Erdman D, Prill M, Iwane M, Shelley L . Field evaluation of TaqMan Array Card (TAC) for the simultaneous detection of multiple respiratory viruses in children with acute respiratory infection. J Clin Virol. 2013; 57(3):254-60. PMC: 7108303. DOI: 10.1016/j.jcv.2013.03.016. View

Oordt-Speets A, Bolijn R, van Hoorn R, Bhavsar A, Kyaw M . Global etiology of bacterial meningitis: A systematic review and meta-analysis. PLoS One. 2018; 13(6):e0198772. PMC: 5995389. DOI: 10.1371/journal.pone.0198772. View

Britz E, Perovic O, von Mollendorf C, von Gottberg A, Iyaloo S, Quan V . The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009-2012. PLoS One. 2016; 11(9):e0163036. PMC: 5036788. DOI: 10.1371/journal.pone.0163036. View

Diallo K, Feteh V, Ibe L, Antonio M, Caugant D, du Plessis M . Molecular diagnostic assays for the detection of common bacterial meningitis pathogens: A narrative review. EBioMedicine. 2021; 65:103274. PMC: 7957090. DOI: 10.1016/j.ebiom.2021.103274. View

Rhoades R, Tabor-Godwin J, Tsueng G, Feuer R . Enterovirus infections of the central nervous system. Virology. 2011; 411(2):288-305. PMC: 3060663. DOI: 10.1016/j.virol.2010.12.014. View

10.

Leber A, Everhart K, Balada-Llasat J, Cullison J, Daly J, Holt S . Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens. J Clin Microbiol. 2016; 54(9):2251-61. PMC: 5005480. DOI: 10.1128/JCM.00730-16. View

11.

Kohil A, Jemmieh S, Smatti M, Yassine H . Viral meningitis: an overview. Arch Virol. 2021; 166(2):335-345. PMC: 7779091. DOI: 10.1007/s00705-020-04891-1. View

12.

Studahl M, Lindquist L, Eriksson B, Gunther G, Bengner M, Franzen-Rohl E . Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management. Drugs. 2013; 73(2):131-58. DOI: 10.1007/s40265-013-0007-5. View

13.

Logan S, MacMahon E . Viral meningitis. BMJ. 2008; 336(7634):36-40. PMC: 2174764. DOI: 10.1136/bmj.39409.673657.AE. View

14.

Weinberg A, Bloch K, Li S, Tang Y, Palmer M, Tyler K . Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis. 2004; 191(2):234-7. DOI: 10.1086/426402. View

15.

Carvalho M, Tondella M, McCaustland K, Weidlich L, McGee L, Mayer L . Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007; 45(8):2460-6. PMC: 1951257. DOI: 10.1128/JCM.02498-06. View

16.

Harvala H, Jasir A, Penttinen P, Pastore Celentano L, Greco D, Broberg E . Surveillance and laboratory detection for non-polio enteroviruses in the European Union/European Economic Area, 2016. Euro Surveill. 2017; 22(45). PMC: 5718392. DOI: 10.2807/1560-7917.ES.2017.22.45.16-00807. View

17.

Waight P, Andrews N, Ladhani S, Sheppard C, Slack M, Miller E . Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015; 15(5):535-43. DOI: 10.1016/S1473-3099(15)70044-7. View

18.

Wang X, Theodore M, Mair R, Trujillo-Lopez E, du Plessis M, Wolter N . Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens. J Clin Microbiol. 2011; 50(3):702-8. PMC: 3295090. DOI: 10.1128/JCM.06087-11. View

19.

Maertens de Noordhout C, Devleesschauwer B, Angulo F, Verbeke G, Haagsma J, Kirk M . The global burden of listeriosis: a systematic review and meta-analysis. Lancet Infect Dis. 2014; 14(11):1073-1082. PMC: 4369580. DOI: 10.1016/S1473-3099(14)70870-9. View

20.

Pilishvili T, Lexau C, Farley M, Hadler J, Harrison L, Bennett N . Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2009; 201(1):32-41. DOI: 10.1086/648593. View